Latest filing published 29 Jul 2026 for Quest Diagnostics INC, €331k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Mark e. Delaney (senior executive) discloses dealings in Quest Diagnostics Inc to SEC (Form 4). In total, 25 filings cover trades dated from 23 February 2023 to 28 July 2026.
Sales make up the whole of the open-market record (3 sales, €533k). The rest of the record consists of 14 share grants and 1 option exercise. So far in 2026, the count stands at no purchases and 1 sale.
Most recently, on 29 July 2026, the filings show an open-market sale worth €331k in Quest Diagnostics Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 25 declarations